Introducing Systane® PRO PRESERVATIVE-FREE: Alcon’s Longest Lasting, Triple-Action Formula for up to 12 Hours of Dry Eye Symptom Relief

TORONTO--(BUSINESS WIRE)--Sep 28, 2026--

Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced the launch of Systane ® PRO Preservative-Free (PF) in Canada as Systane’s most advanced formula. Systane PRO PF is the longest lasting dry eye symptom relief eye drop for all types of dry eye in the Systane portfolio with a unique triple action, preservative-free formula that provides up to 12 hours of dry eye relief. 1* The product is now available in Canada.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260928269219/en/

Dry eye disease (DED) is one of the most common ocular surface disorders, affecting an estimated 6 million people in Canada and 1.6 billion globally. 6 Building on Systane’s legacy as the #1 global brand of artificial tears, 5 the new formulation includes HP-guar, hyaluronic acid (HA), nano-sized lipids, and the demulcent propylene glycol to hydrate, restore, and protect dry eyes, providing rapid and continued dry eye symptom relief from the first drop. 2-4, 7-9*

“At Alcon, we are committed to ensuring that dry eye sufferers can get the relief they deserve, which is why we are proud to unveil Systane PRO PF, the longest lasting dry eye symptom relief eye drop in the Systane portfolio,” said Vanessa Johari Hansen, Country Franchise Head, Vision Care, Alcon Canada. 2 “Systane PRO’s PF formula works to provide sustained hydration, restore tear film stability, and protect against further irritation of dry eyes.” 3-4

Patients with dry eyes often experience symptoms when moisture retention and tear stability are impacted by a variety of factors, including aging, environment, and digital device use. 10 Combatting these everyday challenges, this new formula covers the surface of the eye for instant hydration and soothing dry eye relief, protects from and prevents further dryness of the eye with long-lasting lubrication, ** and stabilizes the tear film to prevent from further evaporation. 2-4^

“I have witnessed firsthand how disruptive, and at times debilitating, dry eye symptoms can be,” said Dr. François Piuze, optometrist and co-owner of the Eye Am clinics in Quebec City and Montreal. For Eye Care Professionals, pinpointing long-lasting solutions for patients to address the symptoms of this complex and multifactorial disease is critical. That is why it is so exciting that patients in Canada can now experience up to 12 hours of dry eye symptom relief with Systane PRO PF.” 2*

As part of Alcon’s ongoing efforts to educate audiences around the effects and treatment of DED, the organization recently partnered with the Tear Film & Ocular Surface Society (TFOS) to develop the DEWS III report, building upon the globally recognized body of work that has helped shape clinical understanding of DED. “The report highlights the multifactorial and symptomatic nature of the disease and the importance of providing personalized treatment strategies,” notes Dr. Piuze. “This includes first-line foundational treatment options with ingredients like HP-guar and hyaluronic acid (HA), based on individual patient risk factors and disease subtypes.”

To learn more about Systane PRO PF, please visit https://systane.myalcon.com/en-ca/products/systane-pro-preservative-free/

Important Information for the Systane ® Family of Products
Systane lubricant eye drops have been clinically proven to reduce the symptoms of dry eye, providing fast, long-lasting relief and comfort. Systane is the #1 global consumer brand of artificial tears. 5 Systane ® COMPLETE provides symptom relief for people who suffer from evaporative dry eye, aqueous tear-deficient dry eye or mixed dry eye. Systane ® ULTRA is designed for dry eye with aqueous deficient patients. Systane ® BALANCE lubricant eye drops are designed specifically for patients with evaporative dry eye associated with meibomian gland dysfunction. Systane ® HYDRATION gives long-lasting relief of dry eye symptoms for moderate or chronic sufferers or patients who are recovering from corneal or other eye surgery.

About Alcon
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries and territories each year living with conditions like cataracts, glaucoma, retinal diseases, and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals, and programs that advance access to quality eye care. Learn more at www.alcon.com.

*47% of patients experience meaningful symptom relief at 12 hours, N = 153.
**Dose: 4 times a day.
^Improvement in NITBUT demonstrated at Day 30 compared to baseline. Dosed 4 times a day. N =316; (p<0.0001).

References

Connect with us on
Facebook
LinkedIn

©2026 Alcon Inc. CA-SAF-2600098

Introducing Systane® PRO Preservative-Free (PF) in Canada.

ARLINGTON, Virginia & REYKJAVIK, Iceland--(BUSINESS WIRE)--Sep 28, 2026--

Kerecis, the company pioneering the use of sustainably sourced fish skin for tissue regeneration, today announced the launch of Compact, a new fish‑skin platform that reimagines fragmented fish skin in a compressed disc format engineered to reduce waste, improve handling, and simplify application. Available as both MariGen ® Compact and SurgiClose ® Compact, Compact delivers the same deep coverage clinicians expect from fragmented fish skin in a format designed for deep wound defects, tunneling wounds, and irregular wound geometries.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260928105491/en/

Deep wounds present a unique challenge for clinicians, often requiring graft material that can conform to tunneling wounds, undermining, and other irregular geometries. Fragmented fish skin has become an important option in these situations because it can build tissue volume and fill complex defects that are difficult to address with traditional graft formats.

Compact builds on that foundation. Delivered in a compressed disc format, it is designed to improve handling and placement while reducing graft waste. After rehydration, providers can position the graft directly within deep wound spaces and irregular defects while maintaining the same regenerative benefits associated with Kerecis' fragmented fish-skin technology.

The new platform will be available through two product families tailored to different clinical settings.

MariGen ® Compact

MariGen Compact is designed for wound specialists managing partial- and full-thickness wounds, including diabetic foot ulcers, pressure injuries, vascular ulcers, and other complex wound defects. The product adheres to and fills deep wound spaces while helping build tissue volume in tunneling and undermining wounds.

SurgiClose ® Compact

SurgiClose Compact is designed for surgical and trauma applications where clinicians must manage deep wound spaces and irregular defects, including degloving injuries, open fractures, surgical wounds, and amputation closures.

Both products will be available in multiple sizes, providing flexibility across a wide variety of wound types and anatomies.

"Compact is one of those products that seems simple, but solves a real problem," said Mike Cadigan, Region US Vice President, Coloplast Wound & Tissue Repair. "Clinicians told us they wanted the same regenerative performance they see with fragmented fish skin in a format that is more practical to use. Compact delivers the same deep coverage they trust, but in a format designed to minimize waste and improve the user experience."

The launch of Compact represents the latest expansion of Kerecis' growing fish-skin portfolio and reflects the company's continued focus on translating clinical insight into practical solutions that fit the realities of modern tissue regeneration.

About Kerecis

Kerecis develops intact fish-tissue derived products for cellular therapy, tissue regeneration, and protection. When grafted onto damaged human tissue or implanted, the patented material supports the body’s own processes to heal and regenerate. Because no viral or prion transfer risk exists between Atlantic cod and humans, Kerecis products are only gently processed and retain their similarity to human tissue. The gentle processing preserves the material’s original three-dimensional structure, maintaining its inherent natural strength, complexity, and molecules (such as fatty acids). Clinical studies show that Kerecis products heal wounds faster than competitors. Kerecis is the only global manufacturer of medical devices containing intact fish-tissue and is the fastest growing company in the U.S. xenograft biologics skin market. Products include SurgiBind ® /SurgiClose ®, GraftGuide ®, MariGen ®, and Shield™ that address various medical complications. Committed to the UN Sustainable Development Goals, Kerecis uses sustainably sourced Icelandic fish processed with renewable energy. Kerecis is a part of the Coloplast Group, a leading supplier of intimate healthcare products. For more information about Kerecis and its clinical research, visit www.kerecis.com.

Trademarks and registered trademarks are the property of their respective owners.

SurgiClose® Compact by Kerecis

SurgiClose® Compact by Kerecis